Back

Moderate mixed aortic valve disease -evaluation, treatment and prognosis of patients referred to heart valve center

28 August 2023 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: The taunt of moderate mixed/multiple valvular disease Aortic Valve Disease, Other ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Petr Lupinek

Institute for Clinical and Experimental Medicine (IKEM), Prague (Czechia)

4 More presentations in this session

Presentation thumbnail
Predictors of long-term outcomes of patients with concomitant moderate aortic and mitral valves diseases: a single tertiary care center experience 2010-2018
Doctor M. Desai (Cleveland, US)
Abstract Slides Video
Presentation thumbnail
Survival and predictors of outcome in moderate mixed aortic valve disease
Doctor K. Patel (London, GB)
Abstract Slides Video
Presentation thumbnail
Aortic stenosis drives the differential in survival in patients with concomitant moderate aortic and mitral valves diseases
Doctor M. Desai (Cleveland, US)
Abstract Slides Video
Presentation thumbnail
The impact of calcium and vitamin D supplement intake on survival in patients with concomitant moderate aortic and mitral valve disease
Doctor M. Desai (Cleveland, US)
Abstract Slides Video

Access the full session

Session thumbnail
The taunt of moderate mixed/multiple valvular disease

The Event

Event poster

ESC Congress 2023

28 August 2023 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Survival and predictors of outcome in moderate mixed aortic valve disease
thumbnail
Congress Presentation
Impact of symptoms and left ventricular systolic function in patients with moderate mixed aortic valve disease
thumbnail
Congress Presentation
Case 1: concomitant aortic regurgitation and aortic stenosis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources